Annual report pursuant to Section 13 and 15(d)

Income Taxes (Narrative) (Details)

v3.10.0.1
Income Taxes (Narrative) (Details) - USD ($)
12 Months Ended
Dec. 31, 2018
Sep. 30, 2018
Sep. 30, 2017
Income Tax Expense (Benefit) [Line Items]      
Corporate income tax rate   21.00% 35.00%
Valuation allowance, deferred tax asset, change in amount   $ 5,500,000 $ 155,000
Alternative Minimum Tax [Member]      
Income Tax Expense (Benefit) [Line Items]      
Prepaid taxes $ 500,000    
Maximum [Member]      
Income Tax Expense (Benefit) [Line Items]      
Operating Loss Carryforwards, Expiration Date Dec. 31, 2037    
Minimum [Member]      
Income Tax Expense (Benefit) [Line Items]      
Operating Loss Carryforwards, Expiration Date Dec. 31, 2022    
Foreign Tax Authority [Member] | Indefinite [Member]      
Income Tax Expense (Benefit) [Line Items]      
Operating loss carryforwards   62,300,000  
Federal [Member]      
Income Tax Expense (Benefit) [Line Items]      
Operating loss carryforwards   33,200,000  
Federal [Member] | 2022 to 2037 [Member]      
Income Tax Expense (Benefit) [Line Items]      
Operating loss carryforwards   14,400,000  
Federal [Member] | Indefinite [Member]      
Income Tax Expense (Benefit) [Line Items]      
Operating loss carryforwards   18,800,000  
State [Member]      
Income Tax Expense (Benefit) [Line Items]      
Operating loss carryforwards   36,200,000  
State [Member] | 2022 to 2037 [Member]      
Income Tax Expense (Benefit) [Line Items]      
Operating loss carryforwards   19,600,000  
State [Member] | Indefinite [Member]      
Income Tax Expense (Benefit) [Line Items]      
Operating loss carryforwards   16,600,000  
U.K. [Member]      
Income Tax Expense (Benefit) [Line Items]      
Valuation allowance, deferred tax asset, change in amount   5,500,000  
U.K. [Member] | The Female Health Company Limited [Member]      
Income Tax Expense (Benefit) [Line Items]      
Valuation allowance, deferred tax asset, change in amount   63,000  
Valuation allowance   $ 2,200,000